FIORINO, GIONATA
 Distribuzione geografica
Continente #
EU - Europa 1.897
NA - Nord America 1.659
AS - Asia 926
SA - Sud America 291
Continente sconosciuto - Info sul continente non disponibili 33
AF - Africa 22
OC - Oceania 3
Totale 4.831
Nazione #
US - Stati Uniti d'America 1.630
RU - Federazione Russa 923
SG - Singapore 437
SE - Svezia 316
CN - Cina 264
BR - Brasile 253
IE - Irlanda 234
DE - Germania 115
HK - Hong Kong 99
FR - Francia 82
GB - Regno Unito 64
UA - Ucraina 59
VN - Vietnam 50
FI - Finlandia 37
IT - Italia 34
AR - Argentina 17
CA - Canada 12
IN - India 11
BD - Bangladesh 9
IQ - Iraq 9
MX - Messico 8
TR - Turchia 8
ZA - Sudafrica 7
CO - Colombia 6
VE - Venezuela 6
BE - Belgio 5
ES - Italia 5
ID - Indonesia 5
JP - Giappone 5
EC - Ecuador 4
KZ - Kazakistan 4
PH - Filippine 4
TN - Tunisia 4
CH - Svizzera 3
EG - Egitto 3
MA - Marocco 3
NL - Olanda 3
PK - Pakistan 3
PL - Polonia 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
DZ - Algeria 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.798
Città #
Moscow 283
Chandler 280
Singapore 264
Dublin 234
Ashburn 204
Dallas 160
Nyköping 133
Jacksonville 128
Beijing 108
Hong Kong 99
San Jose 66
The Dalles 53
Council Bluffs 49
Dearborn 45
Lancaster 39
Lauterbourg 39
Princeton 38
Los Angeles 36
Medford 36
Cambridge 35
Des Moines 31
Boardman 28
Munich 26
Frankfurt am Main 19
Turku 19
São Paulo 18
Ann Arbor 17
Buffalo 16
Ho Chi Minh City 16
Belo Horizonte 15
Rio de Janeiro 14
Tianjin 14
Jinan 13
Shenyang 13
Orem 11
Brooklyn 10
Guangzhou 10
Redondo Beach 10
Santa Clara 10
San Mateo 9
Hanoi 8
New York 8
Helsinki 7
Curitiba 6
Düsseldorf 6
London 6
Pozzuolo Martesana 6
Wilmington 6
Zhengzhou 6
Brasília 5
Brussels 5
Hebei 5
Johannesburg 5
Phoenix 5
Porto Alegre 5
Santo André 5
Washington 5
Bremen 4
Caracas 4
Da Nang 4
Denver 4
Messina 4
Rome 4
Shenzhen 4
Taizhou 4
Tokyo 4
Woodbridge 4
Atlanta 3
Biên Hòa 3
Bogotá 3
Boston 3
Cairo 3
Campinas 3
Canoas 3
Chicago 3
Fuzhou 3
Guarulhos 3
Haiphong 3
Hangzhou 3
Houston 3
Istanbul 3
Itajubá 3
João Pessoa 3
Lanzhou 3
Maceió 3
Manchester 3
Nanchang 3
Philadelphia 3
Stockholm 3
Vancouver 3
Amman 2
Aparecida de Goiânia 2
Aracaju 2
Baghdad 2
Baku 2
Barra Mansa 2
Can Tho 2
Carapicuíba 2
Caxias do Sul 2
Changsha 2
Totale 2.876
Nome #
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 178
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 163
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 159
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 156
Different Segmental Transit Time (TT) Through the Small Bowel May Affect Wireless Capsule (WC) Endoscopy 156
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 153
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 150
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 150
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 146
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 145
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 143
Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner? 142
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 142
Acute Severe Colitis: Infliximab and/or Cyclosporine? 142
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply 139
Familial aggregation in inflammatory bowel disease: Is it genes or environment? 139
Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. 138
Adalimumab in ulcerative colitis: hypes and hopes 134
Anti-TNF Therapy in Inflammatory Bowel Diseases 132
A prospective comparison between 1.5T magnetic resonance and 3T magnetic resonance in ileo-colonic Crohn’s disease: a single center experience. 130
Biological Therapy for Ulcerative Colitis: what is after Anti-TNF. 121
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 117
Postoperative recurrence of Crohn's disease and videocapsule endoscopy: it is necessary to leave no stone unturned. 102
Videocapsule Endoscopy in Portal Hypertension 100
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 99
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases. 96
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. 96
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. 95
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. 93
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. 92
Safety of a (H1N1)V Vaccine in patients with inflammatory bowel disease treated with immunomodulators and biologicals 91
Risk of postoperative recurrence and postoperative management of Crohn's disease. 85
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 84
New drug delivery systems in inflammatory bowel disease: MMX and taylored delivery to the gut. 84
The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. 82
MRI in Crohn's disease-current and future clinical applications. 79
Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy. 73
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 72
Mucosal healing in Ulcerative Colitis: Where do we Stand? 71
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease. 67
null 37
null 31
null 27
Totale 4.831
Categoria #
all - tutte 16.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022245 0 20 3 12 5 1 8 8 1 36 54 97
2022/2023797 73 71 42 102 50 80 15 34 308 10 8 4
2023/2024189 14 29 7 48 20 30 3 13 2 16 0 7
2024/2025729 5 6 25 49 26 28 24 135 204 40 51 136
2025/20262.091 54 158 125 84 158 552 269 294 241 90 23 43
2026/202782 22 60 0 0 0 0 0 0 0 0 0 0
Totale 4.831